ScholarIQanswers from OpenAlex & ORCID
Daniel A. Laheru
ResearcherPublications, citations & collaboration network
Daniel A. Laheru is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Daniel A. Laheru have?
ScholarIQindexed works
Daniel A. Laheru has 645 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Daniel A. Laheru have?
ScholarIQcitation count
Daniel A. Laheru has 36,941 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Daniel A. Laheru?
ScholarIQh-index
Daniel A. Laheru has an h-index of 78 in OpenAlex.
What is the i10-index of Daniel A. Laheru?
ScholarIQi10-index
Daniel A. Laheru has an i10-index of 172 in OpenAlex.
What is the ORCID of Daniel A. Laheru?
ScholarIQorcid
The ORCID for Daniel A. Laheru is on the source record.
What is the OpenAlex record for Daniel A. Laheru?
ScholarIQopenalex
The OpenAlex for Daniel A. Laheru is on the source record.
What are the most-cited papers on Daniel A. Laheru?
ScholarIQmost cited works
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda, Mark Sausen, Rebecca Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R. Bartlett, Hao Wang, Brandon Luber, Rhoda M. Alani, Emmanuel S. Antonarakis, Nilofer S. Azad, Alberto Bardelli, Henry Brem, John L. Cameron, Clarence Lee, Leslie A. Fecher, Gary L. Gallia, Peter Gibbs, Dung T. Le, Robert Giuntoli, Michael Goggins, Michael D. Hogarty, Matthias Holdhoff, Seung‐Mo Hong, Yuchen Jiao, Hartmut Juhl, Jaeyeon Kim, Giulia Siravegna, Daniel A. Laheru, Calogero Lauricella, Michael Lim, Evan J. Lipson, Suely Kazue Nagahashi Marie, George J. Netto, Kelly S. Oliner, Alessandro Olivi, Louise Olsson, Gregory J. Riggins, Andrea Sartore‐Bianchi, Kerstin Schmidt, le-Ming Shih, Sueli Mieko Oba‐Shinjo, Salvatore Siena, Dan Theodorescu, Jeanne Tie, Timothy T. Harkins, Silvio Veronese, Tian‐Li Wang, Jon Weingart, Christopher L. Wolfgang, Laura D. Wood, Dongmei Xing, Ralph H. Hruban, Jian Wu, Peter J. Allen, C. Max Schmidt, Michael A. Choti, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis A. Díaz
<i>DPC4</i> Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
Christine A. Iacobuzio–Donahue, Baojin Fu, Shinichi Yachida, Mingde Luo, Hisashi Abe, Clark M. Henderson, F Vilardell, Zheng Wang, Jesse W. Keller, Priya R. Banerjee, Joseph M. Herman, John L. Cameron, Charles J. Yeo, Marc K. Halushka, James R. Eshleman, Marian Raben, Alison P. Klein, Ralph H. Hruban, Manuel Hidalgo, Daniel A. Laheru
Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi, Tim F. Greten, Todd S. Crocenzi, Gregory M. Springett, Michael A. Morse, Herbert J. Zeh, Deirdre Jill Cohen, Robert L. Fine, Beth Onners, Jennifer N. Uram, Daniel A. Laheru, Eric R. Lutz, Sara Solt, Aimee Murphy, Justin Skoble, Ed Lemmens, John Grous, Thomas W. Dubensky, Dirk G. Brockstedt, Elizabeth M. Jaffee
Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
Georgios Gemenetzis, Vincent P. Groot, Alex B. Blair, Daniel A. Laheru, Lei Zheng, Amol Narang, Elliot K. Fishman, Ralph H. Hruban, Jun Yu, Richard A. Burkhart, John L. Cameron, Matthew J. Weiss, Christopher L. Wolfgang, Jin He
A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
Dung T. Le, Dirk G. Brockstedt, Ran Nir‐Paz, Johannes Hampl, Shruti Mathur, John Nemunaitis, Daniel H. Sterman, Raffit Hassan, Eric R. Lutz, Bentley Moyer, Martin Giedlin, Jana-Lynn Louis, Elizabeth A. Sugar, Alice Pons, Andrea L. Cox, Jordana Levine, Aimee Murphy, Peter B. Illei, Thomas W. Dubensky, Joseph E. Eiden, Elizabeth M. Jaffee, Daniel A. Laheru